Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy

NCT07746882 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

680

Enrollment

OTHER

Sponsor class

Conditions

Stroke
Acute Ischemic Stroke

Interventions

DRUG: Rivaroxaban, or Edoxaban , or Apixaban , or Dabigatran
DRUG: Aspirin

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine